Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV002514541 | SCV003441004 | pathogenic | Phenylketonuria | 2023-10-08 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with cysteine, which is neutral and slightly polar, at codon 352 of the PAH protein (p.Gly352Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with PAH-related conditions (PMID: 16601866, 32668217). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 102497). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PAH protein function. For these reasons, this variant has been classified as Pathogenic. |
Intergen, |
RCV002514541 | SCV004035223 | likely pathogenic | Phenylketonuria | 2023-09-19 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV002514541 | SCV004201981 | likely pathogenic | Phenylketonuria | 2022-05-03 | criteria provided, single submitter | clinical testing | |
De |
RCV000088728 | SCV000119310 | not provided | not provided | no assertion provided | not provided |